Read more
9:55 AM ยท 21 January 2025

Moderna secures funding to develop bird flu vaccine; shares gain 4.5% ๐Ÿ’‰

-
-
Open account Download free app

Shares of Moderna (MRNA.US), which is best known as a major player in the international vaccine market, gained nearly 4.5% today after it received a government grant to, among other things, accelerate the development of a proprietary vaccine for avian flu.      

The funding package will finance the expansion of clinical trials for up to five additional avian flu subtypes and provide additional support for late-stage development and licensing of prepandemic mRNA-based vaccines. The grant was made before the inauguration of Donald Trump's presidency.   

The company's fundamental situation does not look very good. The company is not generating profits, behind which is an irregular and small revenue structure. Debt is growing, and with it, so is the overall employment level. The company's spending pressure remains very high. The company's shares have lost nearly 66% over the past year. Source: XTB 

The company's shares are trading at the lowest levels seen since 2020. Source: xStation 

23 January 2026, 9:23 AM

Intel: Solid Results, But the Market Says "Not Enough"

22 January 2026, 3:59 PM

Meta Platforms shares surge amid Jefferies 'Buy' recommendation ๐Ÿ“ˆ

22 January 2026, 3:36 PM

US Open: Rebound attempt on Wall Street ๐Ÿ“ˆMeta Platforms surges 3.5%

22 January 2026, 2:24 PM

Stock of the Week: TSMC, the heart of the global AI revolution (January 22, 2026)

Join over 2 000 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissรฃo de Valores Mobiliรกrios (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits